Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVAC: Repeated Dose SARS-CoV-2 Vaccination in Kidney Transplant Patients
NCT05030974Phase 4Completed
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of elasomeran in coronavirus disease 2019 (COVID-19), sponsored by University Medical Center Groningen. Started Oct 2021; status: completed.
02
Drugs
elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05030974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05030974.